News
The U.S. clinical laboratory services market expands through regulatory-driven compliance investments, precision-genomics adoption, AI automation, outreach partnerships, reimbursement reforms, ...
Receiving ganciclovir prophylaxis did not have a benefit on respiratory support-free days vs. placebo in adults with ...
Department of Pharmacology and Molecular Sciences, Johns Hopkins University, Baltimore, United States ...
An 'AI scientist', working in collaboration with human scientists, has found that combinations of cheap and safe drugs – used ...
An 'AI scientist', working in collaboration with human scientists, has found that combinations of cheap and safe drugs - used to treat conditions such ...
HepQuant, LLC, a leader in developing noninvasive, blood-based, quantitative testing to assess liver health, is proud to announce ISO 13485 certification as its latest milestone in operational ...
Background Pulmonary hypertension (PH) is a progressive cardiopulmonary condition associated with increased morbidity and ...
Global Drug Screening Market is estimated at $4.8 Bn (2020) growing at a CAGR of 15.8% through 2020-2025. The market growth is driven by growing drug use after COVID-19 pandemic and increase in abuse ...
Objective Quality improvement (QI) practices and scholarship are increasingly concerned with environmental sustainability ...
Objective Neonatal sepsis is a significant cause of morbidity and mortality, particularly in preterm infants. Despite its ...
YUFLYMA® (adalimumab-aaty) is a high-concentration (100mg/mL) and citrate-free formulation of Humira® (adalimumab) biosimilar ...
President Donald Trump will reintroduce a sweeping Medicare drug-pricing plan that failed to advance in his first term.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results